GF
AVDL

Gabelli Funds’s Avadel Pharmaceuticals AVDL Stock Holding History

Gabelli Funds’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-283,734
Closed -$6.11M – 1269
2025
Q4 		$6.11M Buy
+283,734
New +$5.51M 0.04% 437

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's AVDL Position: Q1 2026 in Review

Gabelli Funds sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 283,734 shares — an estimated $6.11M sold.

Gabelli Funds first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $6.11M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Gabelli Funds reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Gabelli Funds sold 283,734 Avadel Pharmaceuticals shares in Q1 2026, an estimated $6.11M.
  • Gabelli Funds first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Gabelli Funds's Avadel Pharmaceuticals position peaked at $6.11M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.